Benefits of Pradaxa^®

Professor John Eikelboom (McMaster University, Canada), Professor Christoph Diener (University of Essen, Germany), Professor Gregory Lip (University of Birmingham Centre for Cardiovascular Sciences, UK) and Professor John Camm (St. George's Hospital, UK) discuss the benefits offered by Pradaxa^® for stroke prevention in patients with atrial fibrillation. Key results from the landmark RE-LY® trial and long-term RELY-ABLE^® study are presented, alongside knowledge about how Pradaxa^® is performing in the real world.